Anti-Insulin Receptor (Phospho-Y1361) Antibody 
Datasheet
MSDS
Description: Rabbit polyclonal antibody to Insulin Receptor (Phospho-Y1361) Immunogen: KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding Y1361 of human Insulin Receptor protein. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/100 - 1/200), IF/IC (1/100 - 1/500) Gene Symbol: INSR Alternative Names: Insulin receptor; IR; CD220Entrez Gene (Human): 3643Entrez Gene (Mouse) : 16337SwissProt (Human): P06213SwissProt (Mouse) : P15208SwissProt (Rat) : P15127Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of Insulin Receptor (pY1361) expression in THP1 (A), HEK293T (B) whole cell lysates. -
Immunohistochemical analysis of Insulin Receptor (Phospho-Y1361) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. -
Immunofluorescent analysis of Insulin Receptor (Phospho-Y1361) staining in HEK293T cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer's disease
Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease